Cyclobutane pyrimidine dimers (CPD) and (6-4) photoproducts are among the main UV-induced DNA lesions. Both types of damage are mostly repaired in prokaryotes by
photolyase enzymes. The repair mechanism of (6-4)
photolyases has still not been fully elucidated, but it is assumed that back rearrangement to the
oxetane occurs prior to repair. In this work, a non-steroidal anti-inflammatory
drug derivative corresponding to the dechlorinated methyl
ester of
carprofen (namely methyl 2-(carbazol-2-yl)propanoate, PPMe) has been used to achieve the photosensitized cycloreversion of model oxetanes (formally resulting from photocycloaddition between
benzophenone and 1,3-dimethylthymine or 2'-
deoxyuridine), by employing fluorescence spectroscopy,
laser flash photolysis, HPLC and NMR. Although
PPMe is able to photoinduce the cycloreversion of both oxetanes, the fluorescence quenching of
PPMe is faster for the 2'-deoxyribose-containing
oxetane; this underlines the importance of the structure in such studies. Moreover,
PPMe was shown to photoinduce the formation of
thymidine cyclobutane dimers through a triplet-triplet energy transfer from a vibrationally excited state, as suggested by the enhanced
PPMe triplet quenching by
thymidine with increasing temperature. These results reveal a dual role of
PPMe in
DNA photosensitization, in that it photoinduces either damage or repair.